Research analysts at William Blair issued their Q1 2026 EPS estimates for shares of Amgen in a research note issued on ...

Half of patients who used delgocitinib cream for chronic hand eczema had a profound response, and a third who stopped ...

Regeneron recently announced it would initiate a quarterly dividend of $0.88, a competitive amount for a company first ...

Last week’s significant research news included positive new Phase III data on Tezspire in nasal polyps from Amgen and ...

With volatility spiking and stock market indexes like the S&P 500 (SNPINDEX: ^GSPC) and Nasdaq Composite (NASDAQINDEX: ^IXIC) ...

Schwab U.S. Dividend Equity ETF excels in market downturns with a 3.6% dividend yield. Find out why SCHD offers lower risk ...

Walgreens jumps as Sycamore agrees to $11.45 a share purchase Sycamore Partners agreed to acquire Walgreens Boots (WBA) in a ...

Analysts at B. Riley cut their FY2025 earnings per share estimates for Cytokinetics in a note issued to investors on Wednesday, March 5th. B. Riley analyst M. Mamtani now anticipates that the ...

How will higher tariffs on goods imported from China, Canada and Mexico impact Home Depot (NYSE:HD) and Lowe's (NYSE:LOW)? We ...

About the ROCKET Phase 3 Program ROCKET is a comprehensive, global Phase 3 clinical trial program comprised of eight studies intended to establish the safety and efficacy profile of rocatinlimab in ...